IMPACT OF PAST COVID-19 INFECTION ON THE SEVERITY OF CORONARY ARTERY DISEASE
Abstract
The gold standard for the treatment of coronary artery disease (CAD) in the case of acute obstruction of the coronary arteries is myocardial revascularization through stent placement, balloon angioplasty, or coronary artery bypass grafting. Advances in myocardial revascularization, the active implementation of drug-eluting stents, and effective antithrombotic therapy have led to a significant reduction in the incidence of coronary restenosis in recent years.
References
1. Petrikov S.S., Ivannikov A.A., Vasilchenko M.K. et al. COVID-19 and the cardiovascular system. Part 1. Pathophysiology, pathomorphology, complications, long-term prognosis. Emergency Medical Care. Journal named after N.V. Sklifosovsky. 2021; 1: 14–26.
2. De Luca G., Debel N., Cercek M. et al. Impact of SARS-CoV-2 positivity on clinical outcomes among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID-19 registry. Atherosclerosis. 2021; 332: 48–54. https://dx.doi.org/10.1016/j.atherosclerosis.2021.06.926.
3. Mahmud E., Dauerman H.L., Welt F.G.P. et al. Management of acute myocardial infarction during the COVID-19 pandemic: A position statement from the SCAI, ACC, and ACEP. Journal of the American College of Cardiology. 2020; 76(11): 75–84.
4. Temporary Methodological Recommendations. Prevention, diagnosis and treatment of novel coronavirus infection (COVID-19). Version 13.1 (17.11.2021). Ministry of Health of Russia. Available at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/058/392/original/BMP-13.1-from-17-11-2021.pdf (Accessed: 11.03.2022).
5. World Health Organization. Top 10 causes of death in the world. 09.12.2022. Available at: https://www.who.int/ru/news-room/fact-sheets/detail/the-top-10-causes-of-death.
6. Heart Disease: Genetics, Pathogenesis, Phenotypes, Diagnostics, Therapy, Comorbidity. Publishing House “PatiSS” LLC, 2020; pp. 13–28.
7. Varga Z. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395: 1417–1418. DOI: 10.1016/S0140-6736(20)30937-5.
8. Zhu Y., Xing W., Wang H., Song J., Sun Z., Li X. Characteristics of patients with ST-segment elevation myocardial infarction (STEMI) at the initial stage of the COVID-19 pandemic: A systematic review and meta-analysis. Infectious Diseases (London). 2021 Nov; 53(11): 865–875.
9. Changal K., Veria S., Mack S., Paternite D., Sheikh S.A., Patel M., Mir T., Sheikh M., Ramanathan P.K. Myocardial injury in hospitalized COVID-19 patients: A retrospective study, systematic review, and meta-analysis. BMC Cardiovascular Disorders. 2021.
10. Angeli F., Marazzato J., Verdecchia P., Balestrino A. Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19. European Journal of Internal Medicine. 2021 Jul; 89: 81–86. DOI: 10.1186/s12872-021-02450-3.
11. Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nature Medicine. 2022; 28(1): 583–590.
12. Available at: https://www.nature.com/articles/s41591-022-01689-3.
